Synapse - Matthew R Femia

Matthew R Femia

Research Focus

Former Employee. Human Oncology and Pathogenesis Program; Research Technician

Recent additions – View all

T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
Meeting Abstract

Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
Molecular Cancer Therapeutics (2019)

Fulltext@MSK | Save
T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
Meeting Abstract

Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
Journal for ImmunoTherapy of Cancer (2019)

Fulltext@MSK | Save
TOX is a critical regulator of tumour-specific T cell differentiation
Journal Article

Scott, A. C.; Dündar, F.; Zumbo, P.; Chandran, S. S.; Klebanoff, C. A.; Shakiba, M.; Trivedi, P.; Menocal, L.; Appleby, H.; Camara, S.; more...
Nature (2019)

Fulltext@MSK | Save

Co-authors at MSK

3

Chandran
3

Klebanoff
2

Klatt
2

Scheinberg
1

Appleby
1

Betel
1

Camara
1

Comen
1

Glickman
1

Hellmann
1

Levy
1

Menocal
1

Philip
1

Schieti...
1

Scott
1

Shakiba
1

Snyder ...
1

Trivedi
1

Walther
1

Wen
1

Zamarin

Types of Work

Publications